Applied DNA Announces Strategy to Address Omicron SARS-CoV-2 Variant, Introduces Linea™ 2.0 COVID-19 Assay Kit
Applied DNA Sciences, Inc. (APDN)
Last applied dna sciences, inc. earnings: 8/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adnas.com/molecular-based-security/investors
Company Research
Source: Business Wire
- Linea™ COVID-19 Assay Kit Likely Subject to Unique Double S-Gene Target Drop, Enables Rapid Reflex Testing of Positive Samples to Confirm Probable Presence of Omicron Without Sequencing -- Company to Submit Validation Data to New York Department of Health for Linea™ 2.0 Assay to Service All safeCircle™ Customers in the Event of Omicron Prevalence - STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, today announced its COVID-19 diagnostic strategy in response to the emergence of Omicron (B.1.1.529), a newly identified SARS-CoV-2 variant of concern. The Company plans to introduce its Linea™ 2.0 COVID-19 Assay (“Linea 2.0”), a new RT-PCR assay for the SARS-CoV-2 E and N genes that builds on the Company’s established COVID-19 line of diagnostics, after submission of its validation data to the New York State Department of
Show less
Read more
Impact Snapshot
Event Time:
APDN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
APDN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
APDN alerts
High impacting Applied DNA Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
APDN
News
- Applied DNA Announces 1-For-20 Reverse Stock Split [Yahoo! Finance]Yahoo! Finance
- Applied DNA Announces 1-For-20 Reverse Stock SplitAccesswire
- Global Authentication and Brand Protection Market Size To Exceed USD 6.24 Billion By 2033 | CAGR Of 8.23% [Yahoo! Finance]Yahoo! Finance
- Applied DNA Sciences, Inc. (NASDAQ: APDN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Applied DNA Sciences, Inc. (NASDAQ: APDN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
APDN
Earnings
- 2/8/24 - Beat
APDN
Sec Filings
- 4/24/24 - Form S-1
- 4/23/24 - Form 8-K/A
- 4/22/24 - Form 8-K
- APDN's page on the SEC website